Jefferies Financial Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$122K Buy
+43,898
New +$177K ﹤0.01% 1167
2023
Q3
– Sell
-93,900
Closed -$2.65M – 2049
2023
Q2
$2.65M Buy
+93,900
New +$2.25M 0.02% 568

Other funds holding ZNTL

Jefferies Financial Group's ZNTL Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 43,898 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in ZNTL as recently as Q2 2023.

Jefferies Financial Group first reported a position in ZNTL in Q2 2023 and has held it in 2 quarters since. The position peaked at $2.65M in Q2 2023. 127 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • Jefferies Financial Group held 43,898 shares of Zentalis Pharmaceuticals worth $122K as of Q3 2026.
  • Zentalis Pharmaceuticals was a new Jefferies Financial Group position in Q3 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1167 holding.
  • Jefferies Financial Group first reported a position in Zentalis Pharmaceuticals in Q2 2023 and has held it in 2 quarters since.
  • Jefferies Financial Group's Zentalis Pharmaceuticals position peaked at $2.65M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.